跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRIENTINE-DRLA trientine dihydrochloride 250 mg capsule bottle - TGA Drug Approval Details
Approvals
/
TGA
/
TRIENTINE-DRLA trientine dihydrochloride 250 mg capsule bottle
Approved
STANDARD
TRIENTINE-DRLA trientine dihydrochloride 250 mg capsule bottle
Dr Reddys Laboratories Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0d6eb803ba6e4cd6
Company
Dr Reddys Laboratories Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
0d6eb803ba6e4cd6
Product Name
TRIENTINE-DRLA trientine dihydrochloride 250 mg capsule bottle
Artg Id
329317
Artg Name
TRIENTINE-DRLA trientine dihydrochloride 250 mg capsule bottle
Sponsor
Dr Reddys Laboratories Australia Pty Ltd
Company Detail Path
/organization/dr-reddys-laboratories-australia-pty-ltd
Artg Date
2021-03-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0d6eb803ba6e4cd6
Type
Standard
Back to TGA Approvals
